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Cellular metabolism is a fundamental mechanism
to provide all cells with energy in the form of
adenosine triphosphate (ATP). The study of
metabolic pathways, however, reawakens horror
memories to many an immunologist – of long
undergraduate lectures describing complicated,
interconnected pathways of countless enzymatic
reactions, regulatory mechanisms and metabolites.
Yet as cellular metabolism has emerged as a critical
modulator of so many aspects of immunity,
immunologists have returned to undergraduate
textbooks to uncover new metabolic-focussed
mechanisms which effect immunity. What has
particularly captured the interest of so many are
the various substrate preferences that different
immune cells exhibit in order to generate ATP, and
the differential ways in which immune cells utilise
metabolic reprogramming to generate specific
metabolites for pathogen defence, signalling,
cytokine production and development. The
number of different immune effector functions
that are supported by distinct metabolic
configurations is ever growing, so much so that
metabolism is becoming as integral to immunity as
the immune cells and mediators themselves
(Figure 1).
One promise of immunometabolism research is
that increased understanding of how pathways of
cellular metabolism influence immune cell
functions will open novel areas for the
manipulation of immunity. This is a particularly
promising avenue in metabolic demanding
microenvironments such as the gut, infected lesions
and tumors, where metabolic crosstalk between
immune cells and commensals, pathogens or
tumors is tightly linked to homeostasis and disease.
Moreover, the influence of systemic factors such as
ageing and the consumption of a ‘Western’ diet
leading to conditions such as obesity add a further
layer of complexity as these can influence local
concentrations of metabolites, resulting in
alterations in immune cell metabolic pathways and
consequently effector functions. The challenge for
all putative therapeutic interventions is to identify
cellular metabolic mechanisms that are specific to
immune cell functions.
This Special Feature of Clinical & Translational
Immunology on Regulation of Immunity and
Infection by Pathways of Cellular Metabolism
comprises five publications that describe recent
advances detailing metabolic mechanisms
that support specific aspects of immunity. The
articles encompass far-reaching aspects of
immunometabolism: from the role of lipids in the
generation of immune cells during haematopoiesis;
how innate and adaptive immune effector
mechanisms are sensitive to altered metabolic
states during obesity and ageing, respectively; to
the specific metabolites and cellular metabolic
mechanisms that support host responses to
infections.
The cellular lipidome is composed of
approximately 100 000 lipids. Best known for their
role as major cellular fuel sources, lipids can also
serve as signalling intermediates and provide
structural integrity to cells. Pernes et al.1 review
the interaction between lipid metabolism and
haematopoiesis, the process responsible for
generating leucocytes. While it is well established
that fatty acid oxidation is a major energy source
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for haematopoietic stem cell self-renewal and
progenitor cell differentiation, the review
highlights other contributions of the lipid
network with an emphasis on non-oxidative lipid
metabolism. Importantly, understanding of lipid
metabolism during haematopoiesis has
consequences for the development of therapeutic
targets to treat haematological malignancies,
including leukaemia.
Currently, it is estimated that there are more
than 2 billion people worldwide who are
overweight or obese. Type 2 immunity, which
involves a complex array of immune cells
including M2 macrophages, eosinophils, ILC2s,
Tregs and iNKT cells, maintains an anti-
inflammatory milieu within adipose tissue. Obesity
disrupts this status leading to inflammation and
insulin resistance. In the review, Harris et al.2
argue that helminth-induced type 2 immunity
helps promote the survival of the infected host, in
part through its impact on adipose tissue. How
helminth infection improves systemic metabolism
presents a unique and exciting opportunity to
identify novel approaches to combat the current
obesity epidemic.
T-cell responses in the elderly are often
dysfunctional resulting in reduced vaccine efficacy
and enhanced vulnerability to infection and
cancer. T cells rely on metabolic pathways for their
homeostasis and the ability to respond to signals
delivered via the T-cell receptor and/or cytokines.
In this review, Quinn et al.3 summarise how
metabolic alterations manifest during ageing and
the impact this has on T-cell immunity. For those
new to the field, the review begins with a concise
overview of the fundamentals of T-cell metabolism
and its regulation during naive and memory T-cell
homeostasis and T-cell activation. How ageing
impacts T-cell signalling is reviewed, including the
shifts in metabolic profiles exhibited by age-
associated T-cell subsets. The authors highlight
how understanding of immunometabolism and
how it impacts T-cell immunity will enable the
design of metabolic interventions to improve T-cell
outcomes in the elderly.
Mitochondria produce ATP that fuels cellular
function. Mitochondrial DNA (mtDNA) originates
from the mitochondrion’s bacterial ancestry, and
its release from mitochondria is detected by
pattern recognition receptors that trigger
immunomodulatory mechanisms. Here, Schroeder
et al.4 review the PRR that sense mtDNA and how
mitochondria impact PRR activity during infection
and disease. The authors discuss the proposed
mechanisms that would enable permeabilisation
of two mitochondrial membranes that envelope
mtDNA and pose hypotheses for mechanisms
by which mtDNA may directly or indirectly drive
NLRP3 signalling. This is important because
mitochondrial disruption and NLRP3
inflammasome activity is implicated in several
clinical contexts including cardiovascular and
neurodegenerative disease.
Peptidoglycan (PG) is a glycopeptide polymer
in the cell wall of nearly all species of both
gram-positive and gram-negative bacteria.
Degradation of PG by bacterial and host enzymes
elicits metabolites that signal microbial immunity
in the host. Sensors of PG metabolites are the
cytosolic nucleotide-binding oligomerisation
domain (NOD) proteins, Nod 1 and 2. In this last
review, Hang et al.5 discuss PG metabolites and
recent efforts to generate chemical derivatives to
increase their clinical use by enhancing potency
and bioavailability and reducing their associated
side effects. How PG metabolites are used as
Figure 1. This Special Feature comprises five articles that detail
different aspects of cellular metabolism that support immune cell
function: the role of lipids in haematopoiesis; the interplay between
type 2 immunity and gut homeostasis and obesity; the contribution
of metabolic decline in ageing to T-cell function; mitochondrial
disruption and host defence; and bacterial metabolites and their
sensing by NOD receptors. The articles detail how, together,
immunology (i.e. tools) and metabolism (i.e. ingredients) combine to
generate host immunity (i.e. donut).
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adjuvants and in cancer treatment is also
reviewed.
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